Yes—but at a slightly smaller dose than teens and adults. Children who are 2 weeks to 12 years old take a twice-daily dose ...

With cases of the flu on the rise, we asked experts what you need to know about an antiviral medication that can ease ...

The first generic of Roche’s flu antiviral Tamiflu has hit the US market. The privately-held generics firm Alvogen has developed the cut-price copy of Tamiflu (oseltamivir) with India’s Natco ...

A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.

Not a substitute for annual influenza vaccination. Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. Not recommended for ...

Children should not be given the anti-viral drug Tamiflu to combat swine flu, Oxford University researchers have said. They urged the United Kingdom Department of Health to urgently rethink its ...

Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.

However, baloxavir may have resulted in treatment resistance in approximately 10% of those treated, the authors noted in JAMA Internal Medicine, which means that monitoring for drug resistance may be ...

Innovations in drug formulations, such as pediatric-friendly suspensions and over-the-counter (OTC) availability, are further broadening the accessibility and appeal of Tamiflu. Key factors ...

Engineering microbes could be our best hope for creating enough antiviral drugs. As fears spread about a potential flu pandemic, Roche's antiviral drug Tamiflu (oseltamivir phosphate) has found ...

The proliferation of generic Tamiflu offerings, especially in cost-sensitive regions like Asia Pacific and Latin America, is boosting accessibility and driving adoption. Furthermore, strategic ...